small-cap

What is making Bellamy's Australia Ltd.’s Stock Price Soar?

Mar 21, 2017 | Team Kalkine
What is making Bellamy's Australia Ltd.’s Stock Price Soar?


BAL Details 
Possible easing in import rules by Chinese regulators drove the stock sentiment: Bellamy's Australia Ltd (ASX: BAL) stock soared 15.7% on March 21, 2017 partly driven by the speculation on probable easing of import rules by Chinese regulators. In terms of performance, BAL had reported a 47% year on year drop in 1H 17 NPAT to $7.2 million. The result was impacted by higher than expected inventory impairments and restructuring charges that totalled $8.6 million (one-off costs). There was also an impact on the operating cash outflows of $23.7 million owing to the inventory build-up. The group has given an outlook for 2H17 for underlying EBIT of $11 million – $15 million and reported EBIT of $9 million - $13 million (including a further $3.2 million in restructuring charges). On the other hand, China supply chain has been rationalised and the group has identified about $8 million in cost savings while supply agreements have been renegotiated. In the past one year, BAL has also been impacted by a multitude of other factors, such as departure of the CEO and demotion of the CFO. The chairman of the group, Mr Rodd Peters, recently confirmed that he no longer is an authorised representative for Black Prince Private Foundation (a shareholder of BAL).In addition to the changes and other updates at the board level, the group also reported about a further representative proceeding filed in the Federal Court of Australia in Victoria against the group with regards to shares acquired by shareholders between April 2016 and December 2016. 

2H 17 Outlook (Source: Company Reports)
 
Stock Performance: BAL stock crashed over 68.8% in the last six months (as at March 20, 2017) impacted by the tightened Chinese regulations on imports, impairments and weak performance. On the other hand, the recent update of a probable easing in import rules by Chinese regulators would give a relief to the infant formula makers and especially the group which has been struggling in the recent months. Risks do prevail with regards to factors relating to regulatory changes and raw material supply. On the contrary, the group is intending to put efforts on its turnaround strategy.We give a “Hold” recommendation at the current price of – $ 4.42


BAL Daily Chart (Source: Thomson Reuters)


Disclaimer
 
The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. Kalkine.com.au and associated pages are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). The information on this website has been prepared from a wide variety of sources, which Kalkine Pty Ltd, to the best of its knowledge and belief, considers accurate. You should make your own enquiries about any investments and we strongly suggest you seek advice before acting upon any recommendation. Kalkine Pty Ltd has made every effort to ensure the reliability of information contained in its newsletters and websites. All information represents our views at the date of publication and may change without notice. To the extent permitted by law, Kalkine Pty Ltd excludes all liability for any loss or damage arising from the use of this website and any information published (including any indirect or consequential loss, any data loss or data corruption). If the law prohibits this exclusion, Kalkine Pty Ltd hereby limits its liability, to the extent permitted by law to the resupply of services. There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product. The link to our Terms & Conditions has been provided please go through them and also have a read of the Financial Services Guide. On the date of publishing this report (mentioned on the website), employees and/or associates of Kalkine Pty Ltd currently hold positions in:  BHP, BKY, KCN, PDN, and RIO. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.

Past performance is not a reliable indicator of future performance.